From: Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD
Characteristic | Subjects with no pneumonic infiltrate identified at any exacerbation (n = 81) | Subjects with ≥1 pneumonic infiltrate identified at exacerbation (n = 46) | P-value | ||||
---|---|---|---|---|---|---|---|
na | Â | na | Â | ||||
Age (years) | 81 | 66.9 | (8.4) | 46 | 66.6 | (9.1) | 0.843 |
Male sex, n (%) | 81 | 44 | (54.3) | 46 | 24 | (52.2) | 0.855 |
Current smokers, n (%) | 81 | 34 | (42.0) | 46 | 20 | (43.5) | 0.508 |
Body mass index (kg/m2) | 81 | 27.8 | (5.5) | 46 | 27.5 | (5.5) | 0.764 |
FEV1 (Litres) | 80 | 1.26 | 0.47 | 46 | 1.08 | (0.99) | 0.036 |
FEV1 (% predicted) | 80 | 49.2 | (15.7) | 46 | 41.7 | (13.0) | 0.007 |
TLCO (mmol/kPa/min)* | 78 | 4.99 | (2.78) | 44 | 3.85 | (1.30) | 0.005 |
6MWD (meters) | 79 | 320.1 | (110.8) | 46 | 256.6 | (100.9) | 0.002 |
CAT score | 80 | 16.3 | (7.8) | 46 | 17.5 | (7.3) | 0.399 |
Prior history of pneumonia (before study enrolment) | 79 | 22 | (27.8) | 46 | 21 | (45.7) | 0.043 |
Influenza vaccination during the year prior to enrolment | 81 | 72 | (88.9) | 46 | 42 | (91.3) | 0.786 |
ICS use | 81 | 69 | (85.2) | 46 | 44 | (95.7) | 0.083 |
Bacteria detected (culture) | 69 | 34 | (49.3) | 41 | 23 | (56.1) | 0.311 |
Bacteria detected (PCR) | 62 | 35 | (56.5) | 40 | 28 | (70.0) | 0.169 |